FDA — authorised 21 January 2015
- Marketing authorisation holder: NOVARTIS PHARMS CORP
- Status: approved
FDA authorised Cosentyx on 21 January 2015
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 21 January 2015.
NOVARTIS PHARMS CORP holds the US marketing authorisation.